PRAC concludes review of new information on the known risk of breast cancer with hormone replacement therapy

The European PRAC has recommended updating the current safety information for HRT, following new evidence confirming the known higher risk of breast cancer, and suggesting this may continue to be increased for at least 10 years after stopping, if it has been used for >5 years.


European Medicines Agency